Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 7Th March, 2024

This is to inform that the Board of Directors of the Company has, at its meeting held on Thursday, 7th March, 2024 (i.e. today), inter-alia, considered and appointed Mr. Tejpreet Singh Chopra (DIN 00053597) as Independent Director of the Company, for a period of 5 consecutive years effective from 1st April, 2024 to 31st March, 2029, subject to the approval of Shareholders. The Board meeting commenced at 3.00 p.m. and ended at 4.30 p.m. This is for your information and record. Thanking You,
07-03-2024
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

This is to inform you that company has received intimation from a shareholder regarding loss of share certificates. The details of the said share certificates enclosed.
06-03-2024
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Board Meeting Intimation for Appointment Of Independent Director

INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/03/2024 ,inter alia, to consider and approve the appointment of an Independent Director on the Board of Directors of the Company.
05-03-2024
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

this is to inform you that the company has received intimation regarding loss of share certificates. Details enclosed.
04-03-2024
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for HDFC Ltd
01-03-2024
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

This is to inform you that the Company has issued duplicate share certificates in respect of the Share Certificates reported to be lost by the shareholders. In accordance with the Regulation 39(3) of the Regulations, the details of the said certificate enclosed herewith.
16-02-2024
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Additional Details For Corporate Announcement - Outcome Of The Board Meeting Of The Company Held On 4Th August, 2023.

Further to our letter ref. number IMCL/CS/BM/2023 dated 4th August, 2023, enclosed please find copy of the letter/ email dated 4th August, 2023 received from Mr. Udit Prakash Rai (DIN:07573658), tendering resignation from the directorship of the Company.
16-02-2024
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Announcement under Regulation 30 (LODR)-Newspaper Publication

we hereby summit copies of the public notice of the financial results published on 07.02.2024 in the financial express all India editions and in Jansatta Delhi editions.
07-02-2024
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Announcement under Regulation 30 (LODR)-Change in Directorate

The Board of Directors of the Company has today i.e. 6th February, 2024 considered and approved the appointment of Mr. Sandip Somany (DIN:00053597) as an Independent Director for a term of 5 years from 1st April, 2024 to 31st March, 2029 subject to approval of shareholders.
06-02-2024
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Un-Audited Financial Results For The Quarter & Nine Months Ended 31St December, 2023.

The Board of Directors of the Company has at its meeting held on 6th February, 2024 inter-alia considered and approved the unaudited financial results for the quarter and nine months ended 31st December, 2023.
06-02-2024
Next Page
Close

Let's Open Free Demat Account